<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="merrf" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">merrf</book-part-id>
      <title-group>
        <title>MERRF</title>
        <alt-title alt-title-type="alt-title">Synonym: Myoclonic Epilepsy Associated with Ragged Red Fibers</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>DiMauro</surname>
            <given-names>Salvatore</given-names>
          </name>
          <degrees>MD</degrees>
          <email>sd12@columbia.edu</email>
          <aff>H Houston Merritt Center<break/>Department of Neurology<break/>Columbia University Medical Center<break/>New York, New York</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hirano</surname>
            <given-names>Michio</given-names>
          </name>
          <degrees>MD</degrees>
          <email>mh29@columbia.edu</email>
          <aff>H Houston Merritt Center<break/>Department of Neurology <break/>Columbia University Medical Center<break/>New York, New York</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2003-06-03" date-type="created">
          <day>3</day>
          <month>6</month>
          <year>2003</year>
        </date>
        <date iso-8601-date="2015-01-29" date-type="updated">
          <day>29</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="melas" document-type="chapter">MELAS</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="mpph" document-type="chapter">MPPH Syndrome</related-object>
      <abstract id="merrf.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>MERRF (<italic toggle="yes">m</italic>yoclonic <italic toggle="yes">e</italic>pilepsy with <italic toggle="yes">r</italic>agged <italic toggle="yes">r</italic>ed <italic toggle="yes">f</italic>ibers) is a multisystem disorder characterized by myoclonus (often the first symptom) followed by generalized epilepsy, ataxia, weakness, and dementia. Onset is usually in childhood, occurring after normal early development. Common findings are hearing loss, short stature, optic atrophy, and cardiomyopathy with Wolff-Parkinson-White (WPW) syndrome. Pigmentary retinopathy and lipomatosis are occasionally observed.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The clinical diagnosis of MERRF is based on the following four "canonical" features: myoclonus, generalized epilepsy, ataxia, and ragged red fibers (RRF) in the muscle biopsy. The mitochondrial DNA (mtDNA) gene <italic toggle="yes">MT-TK</italic> encoding tRNA<sup>Lys</sup> is the gene most commonly associated with MERRF. The most common pathogenic variant, present in more than 80% of affected individuals with typical findings, is an A-to-G transition at nucleotide 8344 (m.8344A&#x0003e;G). Pathogenic variants in <italic toggle="yes">MT-TF</italic>, <italic toggle="yes">MT-TL1</italic>, <italic toggle="yes">MT-TI</italic>, and <italic toggle="yes">MT-TP</italic> have also been described in a subset of individuals with MERRF. Pathogenic variants are usually present in all tissues and are conveniently detected in mtDNA from blood leukocytes. However, the occurrence of "heteroplasmy" in disorders of mtDNA can result in varying tissue distribution of mutated mtDNA. Hence, in individuals having few symptoms consistent with MERRF or in asymptomatic maternal relatives of an affected individual, the pathogenic variant may be undetectable in mtDNA from leukocytes and may only be detected in other tissues, such as cultured skin fibroblasts, urinary sediment, oral mucosa, saliva, hair follicles, or (most reliably) skeletal muscle.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Conventional antiepileptic drugs for seizures; physical therapy to improve any impaired motor function; aerobic exercise; standard pharmacologic therapy for cardiac symptoms. Levetiracetam, clonazepam, zonisamide, and valproic acid (VPA) have been used to treat myoclonic epilepsy; however, VPA may cause secondary carnitine deficiency and should be avoided or used with L-carnitine supplementation.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Coenzyme Q<sub>10</sub> (50-100 mg 3x/day) and L-carnitine (1000 mg 3x/day) are often used in hopes of improving mitochondrial function.</p>
          <p><italic toggle="yes">Surveillance:</italic> Routine evaluations every 6-12 months initially; annual neurologic, ophthalmologic, cardiology (electrocardiogram and echocardiogram), and endocrinologic evaluations (fasting blood sugar and TSH) evaluations.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> During pregnancy, affected or at-risk women should be monitored for diabetes mellitus and respiratory insufficiency, which may require therapeutic interventions.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>MERRF is caused by pathogenic variants in mtDNA and is transmitted by maternal inheritance. The father of a proband is not at risk for having the mtDNA pathogenic variant. The mother of a proband usually has the mtDNA pathogenic variant and may or may not have symptoms. A male with a mtDNA pathogenic variant cannot transmit the pathogenic variant to any of his offspring. A female with the pathogenic variant (whether affected or unaffected) transmits the pathogenic variant to all of her offspring. Prenatal diagnosis for MERRF is possible if an mtDNA pathogenic variant has been detected in the mother. However, because the mutational load in the mother's tissues and in the fetal tissues sampled (i.e., amniocytes and chorionic villi) may not correspond to that of other fetal tissues and because the mutational load in tissues sampled prenatally may shift in utero or after birth secondary to random mitotic segregation, prediction of the phenotype from prenatal studies is not possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="merrf.Diagnosis">
        <title>Diagnosis</title>
        <sec id="merrf.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>The clinical diagnosis of MERRF (<italic toggle="yes">m</italic>yoclonic <italic toggle="yes">e</italic>pilepsy with <italic toggle="yes">r</italic>agged <italic toggle="yes">r</italic>ed <italic toggle="yes">f</italic>ibers) is based on the following four "canonical" features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Myoclonus</p>
            </list-item>
            <list-item>
              <p>Generalized epilepsy</p>
            </list-item>
            <list-item>
              <p>Ataxia</p>
            </list-item>
            <list-item>
              <p>Ragged-red fibers (RRF) in the muscle biopsy or identification of a mtDNA pathogenic variant</p>
            </list-item>
          </list>
          <p>Additional frequent manifestations include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Sensorineural hearing loss</p>
            </list-item>
            <list-item>
              <p>Myopathy</p>
            </list-item>
            <list-item>
              <p>Peripheral neuropathy</p>
            </list-item>
            <list-item>
              <p>Dementia</p>
            </list-item>
            <list-item>
              <p>Short stature</p>
            </list-item>
            <list-item>
              <p>Exercise intolerance</p>
            </list-item>
            <list-item>
              <p>Optic atrophy</p>
            </list-item>
          </list>
          <p>Less common clinical signs (seen in &#x0003c;50% of affected individuals) include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Cardiomyopathy</p>
            </list-item>
            <list-item>
              <p>Pigmentary retinopathy</p>
            </list-item>
            <list-item>
              <p>Pyramidal signs</p>
            </list-item>
            <list-item>
              <p>Ophthalmoparesis</p>
            </list-item>
            <list-item>
              <p>Multiple lipomas</p>
            </list-item>
          </list>
        </sec>
        <sec id="merrf.Testing">
          <title>Testing</title>
          <p><bold>Lactic acidosis both in blood and in the CSF.</bold> In individuals with MERRF, the concentrations of lactate and pyruvate are commonly elevated at rest and increase excessively after moderate activity.</p>
          <p>Note: Other situations (unrelated to the diagnosis of MERRF or other mitochondrial diseases) in which lactate and pyruvate can be elevated are acute neurologic events such as seizure or stroke.</p>
          <p><bold>Elevated CSF protein concentration.</bold> The concentration of CSF protein may be increased but rarely surpasses 100 mg/dL.</p>
          <p><bold>Electroencephalogram (EEG)</bold> usually shows generalized spike and wave discharges with background slowing, but focal epileptiform discharges may also be seen.</p>
          <p><bold>Electrocardiogram</bold> often shows pre-excitation; heart block has not been described.</p>
          <p><bold>Electromyogram (EMG)</bold> and <bold>nerve conduction velocity (NCV)</bold> studies are consistent with a myopathy, but neuropathy may coexist.</p>
          <p><bold>Brain MRI</bold> often shows brain atrophy and basal ganglia calcification. Bilateral putaminal necrosis and atrophy of the brain stem and cerebellum have been reported [<xref ref-type="bibr" rid="merrf.REF.orcesi.2006.79">Orcesi et al 2006</xref>, <xref ref-type="bibr" rid="merrf.REF.ito.2008.392">Ito et al 2008</xref>].</p>
          <p><bold>Muscle biopsy</bold> typically shows ragged red fibers (RRF) with the modified Gomori trichrome stain and hyperactive fibers with the succinate dehydrogenase (SDH) stain. Both RRF and some non-RRF fail to stain with the histochemical reaction for cytochrome <italic toggle="yes">c</italic> oxidase (COX). Occasionally, RRF may not be observed [<xref ref-type="bibr" rid="merrf.REF.mancuso.2007.1058">Mancuso et al 2007</xref>].</p>
          <p><bold>Respiratory chain studies.</bold> Biochemical analysis of respiratory chain enzymes in muscle extracts usually shows decreased activity of respiratory chain complexes containing mtDNA-encoded subunits, especially COX deficiency. However, biochemical studies may also be normal.</p>
          <p><bold>Genes.</bold>
<italic toggle="yes">MT-TK</italic>, <italic toggle="yes">MT-TF</italic>, <italic toggle="yes">MT-TL1</italic>, <italic toggle="yes">MT-TI</italic>, and <italic toggle="yes">MT-TP</italic> are the genes in which pathogenic variants are known to cause MERRF.</p>
          <p>
            <bold>Clinical testing</bold>
          </p>
          <table-wrap id="merrf.T.summary_of_molecular_genetic_tes" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in MERRF</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">MT-TK</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Targeted analysis of m.8344A&#x0003e;G<hr/></td>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;80%&#x000a0;<sup>2</sup><hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Targeted analysis for pathogenic variants&#x000a0;<sup>3</sup><hr/></td>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~10%&#x000a0;<sup>2</sup><hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TF</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_2" rowspan="4" valign="middle" align="left" colspan="1">Sequence analysis / scanning for pathogenic variants&#x000a0;<sup>4,&#x000a0;5</sup><hr/></td>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1">&#x0003c;5%&#x000a0;<sup>6</sup><hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TL1</italic>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TI</italic>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TP</italic>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">mtDNA<hr/></td>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis / scanning for pathogenic variants <sup>4</sup><hr/></td>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">90%-95%&#x000a0;<sup>7</sup><hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_merrf.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003c;5%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="merrf.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="merrf" object-id="merrf.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="merrf.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="merrf.TF.1.2">
                <label>2. </label>
                <p>Four <italic toggle="yes">MT-TK</italic> pathogenic variants (<xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8344A&#x0003e;G</xref>, <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8356T&#x0003e;C</xref>, <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8363G&#x0003e;A</xref>, and <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8361G&#x0003e;A</xref>) account for approximately 90% of pathogenic variants in individuals with MERRF.</p>
              </fn>
              <fn id="merrf.TF.1.3">
                <label>3. </label>
                <p>Pathogenic variants detected: m.8356T&#x0003e;C, m.8363G&#x0003e;A, and m.8361G&#x0003e;A. Note: Pathogenic variants included in a panel may vary by laboratory.</p>
              </fn>
              <fn id="merrf.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, partial-, whole-, or multigene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="merrf.TF.1.5">
                <label>5. </label>
                <p>Pathogenic variants detected: <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.611G&#x0003e;A</xref>, <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.3243A.G</xref>, <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.4279A&#x0003e;G</xref>, <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.4284G&#x0003e;A</xref>, and <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.15967G&#x0003e;A</xref></p>
              </fn>
              <fn id="merrf.TF.1.6">
                <label>6. </label>
                <p>The proportion of MERRF caused by the pathogenic variants listed in footnote 4</p>
              </fn>
              <fn id="merrf.TF.1.7">
                <label>7. </label>
                <p>Sequence analysis / scanning for pathogenic variants is used to detect pathogenic variants throughout mtDNA and is not specific for MERRF. The overall variant detection rate for MERRF by scanning/sequence analysis of mtDNA is 90%-95%.</p>
              </fn>
              <fn id="merrf.TF.1.8">
                <label>8. </label>
                <p>One child with MERRF was found to have two mtDNA deletions in a buccal swab suggesting an autosomal disorder with multiple mtDNA deletions; however, the causative nuclear gene was not identified [<xref ref-type="bibr" rid="merrf.REF.yorns.2012.398">Yorns et al 2012</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="merrf.Testing_Strategy">
          <title>Testing Strategy</title>
          <sec id="merrf.Establishing_the_Diagnosis_in_a_Pr">
            <title>Establishing the Diagnosis in a Proband</title>
            <p>Pathogenic variants are usually present in all tissues and can be detected in mtDNA from blood leukocytes in individuals with typical MERRF; however the occurrence of "heteroplasmy" in disorders of mtDNA can result in varying tissue distribution of mutated mtDNA. Hence, in individuals having few symptoms consistent with MERRF or in asymptomatic maternal relatives, the pathogenic variant may be undetectable in mtDNA from leukocytes and may only be detected in other tissues, such as cultured skin fibroblasts, urinary sediment, oral mucosa, saliva, hair follicles, or (most reliably) skeletal muscle.</p>
            <p><bold>One genetic testing strategy</bold> is serial single-gene molecular genetic testing based on the order in which pathogenic variants most commonly occur:</p>
            <list list-type="bullet">
              <list-item>
                <p>Typically, blood leukocyte DNA is initially screened for pathogenic variants in <italic toggle="yes">MT-TK</italic> using targeted analysis for the <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8344A&#x0003e;G</xref> pathogenic variant followed by screening for the <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8356T&#x0003e;C</xref>, <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8363G&#x0003e;A</xref>, and <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8361G&#x0003e;A</xref> pathogenic variants.Alternatively, DNA from buccal mucosa, muscle, or urine sediment can be screened for mtDNA pathogenic variants.</p>
              </list-item>
              <list-item>
                <p>If the four most frequent <italic toggle="yes">MT-TK</italic> pathogenic variants are excluded, sequence analysis of <italic toggle="yes">MT-TF, MT-TL1, MT-TI,</italic> and <italic toggle="yes">MT-TP</italic> may be considered. Note: In simplex cases (i.e., a single occurrence in a family) with myoclonus, epilepsy, and ataxia, muscle biopsy is often useful in detecting signs of mitochondrial dysfunction such as ragged red fibers, cytochrome <italic toggle="yes">c</italic> oxidase-deficient fibers, or biochemical defects of mitochondrial respiratory chain enzymes.</p>
              </list-item>
            </list>
            <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">MT-TK</italic>, <italic toggle="yes">MT-TF</italic>, <italic toggle="yes">MT-TL1, MT-TI,</italic> and <italic toggle="yes">MT-TP,</italic> and other genes of interest (see <xref ref-type="sec" rid="merrf.Differential_Diagnosis">Differential Diagnosis</xref>) or full mtDNA sequencing. Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
          </sec>
        </sec>
      </sec>
      <sec id="merrf.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="merrf.Clinical_Description">
          <title>Clinical Description</title>
          <p>MERRF is a multisystem disorder characterized by myoclonus, which is often the first symptom, followed by generalized epilepsy, ataxia, weakness, and dementia. Onset is usually in childhood, after normal early development. <xref ref-type="table" rid="merrf.T.signs_and_symptoms_seen_in_62_in">Table 2</xref> lists the symptoms and signs seen in 62 affected individuals [<xref ref-type="bibr" rid="merrf.REF.hirano.1996">Hirano &#x00026; DiMauro 1996</xref>]. About 80% (34/42) had a family history compatible with maternal inheritance, but not all maternal relatives were affected and not all of those affected had classic features of MERRF. For example, seven symptomatic relatives had "limb-girdle myopathy" as the only manifestation. Depression may be an under-recognized feature of MERRF [<xref ref-type="bibr" rid="merrf.REF.molnar.2009.264">Molnar et al 2009</xref>].</p>
          <p>Cardiac involvement has been reported to be frequent in individuals with the <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8344A&#x0003e;G</xref> pathogenic variant in <italic toggle="yes">MT-TK</italic> [<xref ref-type="bibr" rid="merrf.REF.wahbi.2010.674">Wahbi et al 2010</xref>]. At diagnosis, eight (44%) of 18 affected individuals had cardiac abnormalities including: dilated cardiomyopathy in four, Wolff-Parkinson-White syndrome in three, incomplete left bundle branch block in one, and premature ventricular beats in one. On follow up, two additional affected individuals developed left ventricular dysfunction and two died of heart failure.</p>
          <p>Occasionally individuals fulfilling the clinical criteria for MERRF also have strokes (MERRF/<related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter">MELAS</related-object> overlap) [<xref ref-type="bibr" rid="merrf.REF.crimi.2003.1857">Crimi et al 2003</xref>, <xref ref-type="bibr" rid="merrf.REF.melone.2004.269">Melone et al 2004</xref>, <xref ref-type="bibr" rid="merrf.REF.naini.2005.473">Naini et al 2005</xref>] or progressive external ophthalmoplegia and retinopathy, reminiscent of <related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">Kearns-Sayre syndrome</related-object> [<xref ref-type="bibr" rid="merrf.REF.nishigaki.2003.334">Nishigaki et al 2003</xref>, <xref ref-type="bibr" rid="merrf.REF.emmanuele.2011.448">Emmanuele et al 2011</xref>, <xref ref-type="bibr" rid="merrf.REF.fujioka.2014.13">Fujioka et al 2014</xref>].</p>
          <p>Maternally inherited spinocerebellar degeneration and Leigh syndrome, atypical Charcot-Marie-Tooth disease (see <related-object link-type="booklink" source-id="gene" document-id="cmt" document-type="chapter">Charcot-Marie-Tooth Overview</related-object>), and Leigh syndrome have been reported as unusual manifestations in families with individuals diagnosed with MERRF.</p>
          <p>High clinical variability is seen in individuals with the <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8344A&#x0003e;G</xref> pathogenic variant in <italic toggle="yes">MT-TK</italic>. In a retrospective analysis of 42 affected individuals plus 282 previously reported individuals with this pathogenic variant, the large majority did not have all four of the canonical features of MERRF. The most common clinical features, in descending order of frequency, were: myoclonus, muscle weakness, ataxia (35%-45%); generalized seizures, hearing loss (25%-34.9%); cognitive impairment, multiple lipomatosis, neuropathy, exercise intolerance (15%-24.9%); and elevated creatine kinase, ptosis/PEO, optic atrophy, cardiomyopathy, muscle wasting, respiratory impairment, diabetes, myalgias, tremor, and migraine headaches (5%-14.9%) [<xref ref-type="bibr" rid="merrf.REF.mancuso.2013.2049">Mancuso et al 2013</xref>].</p>
          <p>Unusual manifestations in individuals with the <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8344A&#x0003e;G</xref> pathogenic variant in <italic toggle="yes">MT-TK</italic> include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Sudden infant death syndrome (SIDS) in an infant girl who had an unsuspected cardiomyopathy with the histologic features of histiocytoid cardiomyopathy [<xref ref-type="bibr" rid="merrf.REF.vallance.2004.538">Vallance et al 2004</xref>]</p>
            </list-item>
            <list-item>
              <p>Spasmodic dysphonia in a woman age 46 years with otherwise fairly typical personal and family history of MERRF [<xref ref-type="bibr" rid="merrf.REF.peng.2003.716">Peng et al 2003</xref>]</p>
            </list-item>
            <list-item>
              <p>Resting muscle pain as the initial symptom in children [<xref ref-type="bibr" rid="merrf.REF.van_de_glind.2007.243">van de Glind et al 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>Myoclonus, epilepsy, and ataxia without ragged red fibers [<xref ref-type="bibr" rid="merrf.REF.mancuso.2007.1058">Mancuso et al 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>Parkinsonism, neuropathy, and myopathy [<xref ref-type="bibr" rid="merrf.REF.horvath.2007.56">Horvath et al 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>Infantile-onset ataxia, myoclonus, and bilateral putaminal necrosis on brain MRI [<xref ref-type="bibr" rid="merrf.REF.orcesi.2006.79">Orcesi et al 2006</xref>]</p>
            </list-item>
            <list-item>
              <p>Sudden respiratory failure in adulthood [<xref ref-type="bibr" rid="merrf.REF.wiedemann.2008.859">Wiedemann et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>Acute central and peripheral nervous system demyelinating disease [<xref ref-type="bibr" rid="merrf.REF.erol.2009.275">Erol et al 2009</xref>]</p>
            </list-item>
            <list-item>
              <p>Stroke-like episodes similar to MELAS [<xref ref-type="bibr" rid="merrf.REF.vastagh.2011.399">Vastagh et al 2011</xref>]</p>
            </list-item>
            <list-item>
              <p>Distal limb weakness along with ptosis and respiratory muscle weakness [<xref ref-type="bibr" rid="merrf.REF.blakely.2014.533">Blakely et al 2014</xref>]</p>
            </list-item>
          </list>
          <p>A boy age six years with the <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.8631G&#x0003e;A</xref> pathogenic variant in <italic toggle="yes">MT-TK</italic> developed seizures and myoclonus, followed by ataxia, cognitive impairment, and sensorineural hearing loss. Maternal relatives were oligosymptomatic [<xref ref-type="bibr" rid="merrf.REF.rossmanith.2003.820">Rossmanith et al 2003</xref>].</p>
          <p>An individual with the <italic toggle="yes">MT-TF</italic>
<xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.611G&#x0003e;A</xref> pathogenic variant had mild truncal and proximal limb weakness, cerebellar ataxia, bilateral Babinski sign, and frequent myoclonic jerks [<xref ref-type="bibr" rid="merrf.REF.mancuso.2004.2119">Mancuso et al 2004</xref>].</p>
          <table-wrap id="merrf.T.signs_and_symptoms_seen_in_62_in" position="anchor" orientation="portrait">
            <label>Table 2. </label>
            <caption>
              <p>Signs and Symptoms Seen in 62 Individuals with MERRF</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Sign/Symptom</th>
                  <th id="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Present/Evaluated</th>
                  <th id="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Percentage</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Myoclonus<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">62/62<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">100%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Epilepsy<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">62/62<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">100%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Normal early development<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">17/17<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">100%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">RRF (ragged red fibers)<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">47/51<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">92%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hearing loss<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">41/45<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">91%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Lactic acidosis<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">24/29<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">83%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Family history<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">34/42<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">81%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Exercise intolerance<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">8/10<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">80%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Dementia<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">39/52<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">75%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Neuropathy<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">17/27<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">63%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Short stature<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4/7<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">57%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Impaired sensation<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">9/18<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">50%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Optic atrophy<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">14/36<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">39%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Cardiomyopathy<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2/6<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">33%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Wolff-Parkinson-White syndrome<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2/9<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">22%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Pigmentary retinopathy<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">4/26<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">15%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Pyramidal signs<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">8/60<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">13%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Ophthalmoparesis<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">3/28<hr/></td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">11%<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Lipomatosis</td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2/60</td>
                  <td headers="hd_h_merrf.T.signs_and_symptoms_seen_in_62_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">3%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>
                  <xref ref-type="bibr" rid="merrf.REF.hirano.1996">Hirano &#x00026; DiMauro [1996]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="merrf.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No clear correlation has been identified between genotype and clinical phenotype for affected individuals, nor is it clear why typical MERRF is associated with pathogenic variants in <italic toggle="yes">MT-TK</italic>.</p>
          <p>For all mtDNA pathogenic variants, clinical expression depends on three factors:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Heteroplasmy.</bold> The relative abundance of mutant mtDNAs</p>
            </list-item>
            <list-item>
              <p><bold>Tissue distribution</bold> of mutant mtDNAs</p>
            </list-item>
            <list-item>
              <p><bold>Threshold effect.</bold> The vulnerability of each tissue to impaired oxidative metabolism</p>
            </list-item>
          </list>
          <p>The tissue vulnerability threshold probably does not vary substantially among individuals, but variable mutational load and tissue distribution may account for the clinical diversity of individuals with MERRF.</p>
          <p>The selective vulnerability of the dentate nucleus of the cerebellum and the olivary nucleus of the medulla is unexplained. Also unexplained is the pathogenesis of the multiple lipomas characteristically associated with pathogenic variants in <italic toggle="yes">MT-TK</italic>.</p>
        </sec>
        <sec id="merrf.Penetrance">
          <title>Penetrance</title>
          <p>See <xref ref-type="sec" rid="merrf.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>.</p>
        </sec>
        <sec id="merrf.Anticipation">
          <title>Anticipation</title>
          <p>No evidence of anticipation has been found, but knowledge of the molecular defect may favor earlier diagnosis in subsequent generations.</p>
        </sec>
        <sec id="merrf.Nomenclature">
          <title>Nomenclature</title>
          <p>Ramsay <xref ref-type="bibr" rid="merrf.REF.hunt.1921.490">Hunt [1921]</xref> described six individuals with a disorder characterized by ataxia, myoclonus, and epilepsy, which he called "dyssynergia cerebellaris myoclonica." Individuals with the diagnosis of Ramsay Hunt syndrome should be investigated for MERRF.</p>
        </sec>
        <sec id="merrf.Prevalence">
          <title>Prevalence</title>
          <p>Three epidemiologic studies of mtDNA-related diseases in northern Europe gave concordantly low estimates for the prevalence of the m.8344A&#x0003e;G pathogenic variant:</p>
          <list list-type="bullet">
            <list-item>
              <p>0-1.5:100,000 in the adult population of northern Finland [<xref ref-type="bibr" rid="merrf.REF.remes.2005.976">Remes et al 2005</xref>]</p>
            </list-item>
            <list-item>
              <p>0.39:100,000 in the adult population of northern England [<xref ref-type="bibr" rid="merrf.REF.schaefer.2008.35">Schaefer et al 2008</xref>]</p>
            </list-item>
            <list-item>
              <p>0-0.25:100,000 in a pediatric population of western Sweden [<xref ref-type="bibr" rid="merrf.REF.darin.2001.377">Darin et al 2001</xref>]</p>
            </list-item>
          </list>
          <p>See <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object> for general prevalence information.</p>
        </sec>
      </sec>
      <sec id="merrf.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>
          <bold>
            <italic toggle="yes">MT-TK</italic>
          </bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond"><bold>m.8344A&#x0003e;G</bold></xref> can also be associated with isolated myopathy, resembling <related-object link-type="booklink" source-id="gene" document-id="lgmd-overview" document-type="chapter">limb-girdle muscular dystrophy</related-object>, or with multiple lipomas, usually located in the neck and shoulders area (Ekbom syndrome). Other clinical presentations of the m.8344A&#x0003e;G pathogenic variant include spinocerebellar degeneration and <related-object link-type="booklink" source-id="gene" document-id="narp" document-type="chapter">Leigh syndrome</related-object> or isolated Leigh syndrome.</p>
          </list-item>
          <list-item>
            <p><xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond"><bold>m.8356T&#x0003e;C</bold></xref><bold>.</bold> In three families with the m.8356T&#x0003e;C pathogenic variant, some affected individuals had typical MERRF but others also had stroke-like episodes and migraine (MERRF/<related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter">MELAS</related-object> overlap).</p>
          </list-item>
          <list-item>
            <p><xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond"><bold>m.8363G&#x0003e;A</bold></xref> has been associated with typical MERRF, but also with cardiomyopathy or Leigh syndrome [<xref ref-type="bibr" rid="merrf.REF.shtilbans.2000.759">Shtilbans et al 2000</xref>].</p>
          </list-item>
        </list>
        <p>
          <bold>
            <italic toggle="yes">MT-TL1</italic>
          </bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond"><bold>m.3243A&#x0003e;G</bold></xref> is associated with multiple phenotypes including MELAS (<italic toggle="yes">m</italic>itochondrial <italic toggle="yes">e</italic>ncephalomyopathy, <italic toggle="yes">l</italic>actic <italic toggle="yes">a</italic>cidosis, and <italic toggle="yes">s</italic>troke-like episodes), maternally inherited diabetes and deafness (MIDD), and chronic progressive external ophthalmoplegia (CPEO).</p>
          </list-item>
          <list-item>
            <p>A MERRF/<related-object link-type="booklink" source-id="gene" document-id="kss" document-type="chapter">Kearns-Sayre syndrome</related-object> (KSS) overlap syndrome has been reported to be caused by the pathogenic variant m.3255G&#x0003e;A in <italic toggle="yes">MT-TL1</italic> (reported in two individuals [<xref ref-type="bibr" rid="merrf.REF.nishigaki.2003.334">Nishigaki et al 2003</xref>, <xref ref-type="bibr" rid="merrf.REF.fujioka.2014.13">Fujioka et al 2014</xref>]) and by the pathogenic variant m.3291T&#x0003e;C in <italic toggle="yes">MT-TL1</italic> (reported in one individual [<xref ref-type="bibr" rid="merrf.REF.emmanuele.2011.448">Emmanuele et al 2011</xref>]).</p>
          </list-item>
        </list>
        <p>
          <bold>
            <italic toggle="yes">MT-TI</italic>
          </bold>
        </p>
        <list list-type="bullet">
          <list-item>
            <p><xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond"><bold>m.15923A&#x0003e;G</bold></xref> has been associated with neonatal weakness, lactic acidosis, hypoglycemia, cardiopulmonary arrest, and early fatality in one individual [<xref ref-type="bibr" rid="merrf.REF.yoon.1993.433">Yoon et al 1993</xref>].</p>
          </list-item>
        </list>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">MT-TF</italic> or <italic toggle="yes">MT-TP</italic>.</p>
      </sec>
      <sec id="merrf.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Neurologic findings.</bold> The differential diagnosis includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Other mitochondrial disorders (see <related-object link-type="booklink" source-id="gene" document-id="mt-overview" document-type="chapter">Mitochondrial Disorders Overview</related-object>)</p>
          </list-item>
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="alpers" document-type="chapter"><bold><italic toggle="yes">POLG</italic>-related disorders</bold></related-object><bold>.</bold> One individual with myoclonus, epilepsy, ataxia, peripheral neuropathy, but no ragged red fibers had autosomal recessive pathogenic variants in <italic toggle="yes">POLG,</italic> which encodes the catalytic subunit of mitochondrial DNA polymerase gamma [<xref ref-type="bibr" rid="merrf.REF.van_goethem.2003.1811">Van Goethem et al 2003</xref>].</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">CARS2</italic>-related disorder.</bold> In two siblings with juvenile-onset MERRF-like severe myoclonus epilepsy who had ataxia, spastic tetraparesis, vision loss, hearing loss, and cognitive decline, a homozygous splice-site variant was identified in <italic toggle="yes">CARS2</italic>, which encodes mitochondrial cysteinyl-tRNA synthetase 2 [<xref ref-type="bibr" rid="merrf.REF.hallmann.2014.2183">Hallmann et al 2014</xref>].</p>
          </list-item>
          <list-item>
            <p><bold>MERRF/</bold><related-object link-type="booklink" source-id="gene" document-id="melas" document-type="chapter"><bold>MELAS</bold></related-object>
<bold>overlap syndrome,</bold> which may initially resemble MERRF but is caused by pathogenic variants in either <italic toggle="yes">MT-ND5</italic> or <italic toggle="yes">MT-TC</italic> [<xref ref-type="bibr" rid="merrf.REF.crimi.2003.1857">Crimi et al 2003</xref>, <xref ref-type="bibr" rid="merrf.REF.dimauro.2005.222">DiMauro &#x00026; Davidzon 2005</xref>, <xref ref-type="bibr" rid="merrf.REF.naini.2005.473">Naini et al 2005</xref>, <xref ref-type="bibr" rid="merrf.REF.herreromart_n.2010.471">Herrero-Mart&#x000ed;n et al 2010</xref>]. One affected individual with MERRF/MELAS overlap syndrome had two pathogenic variants: the <italic toggle="yes">MT-TL1</italic> variant m.3243A&#x0003e;G (the most frequent cause of MELAS) and the <italic toggle="yes">MT-TK</italic> variant m.8356T&#x0003e;C (a rare cause of MERRF) [<xref ref-type="bibr" rid="merrf.REF.nakamura.2010.659">Nakamura et al 2010</xref>].</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">MT-TL2</italic>-related disorder.</bold> One affected individual had clinical features of MERRF and neuropathy-ataxia-retinitis pigmentosa (NARP) caused by the pathogenic variant m.12300G&#x0003e;A in <italic toggle="yes">MT-TL2</italic> encoding mitochondrial tRNALeu(CUN) (tRNA<sup>Leu(CUN)</sup>) [<xref ref-type="bibr" rid="merrf.REF.mart_njim_nez.2012.288">Mart&#x000ed;n-Jim&#x000e9;nez et al 2012</xref>].</p>
          </list-item>
          <list-item>
            <p>Syndromes characterized by ataxia (e.g., <related-object link-type="booklink" source-id="gene" document-id="drpla" document-type="chapter">DRPLA</related-object>; see also <related-object link-type="booklink" source-id="gene" document-id="ataxias" document-type="chapter">Hereditary Ataxia Overview</related-object>) and myoclonus epilepsy, including <related-object link-type="booklink" source-id="gene" document-id="epm1" document-type="chapter">Unverricht-Lundborg disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="lafora" document-type="chapter">Lafora disease</related-object>, <related-object link-type="booklink" source-id="gene" document-id="ncl" document-type="chapter">neuronal ceroid lipofuscinosis</related-object>, and sialidosis [<xref ref-type="bibr" rid="merrf.REF.zupanc.2004.156">Zupanc &#x00026; Legros 2004</xref>]</p>
          </list-item>
        </list>
        <p>The multisystem involvement, lactic acidosis, evidence of maternal inheritance, and the muscle biopsy with RRF (ragged red fibers) distinguish MERRF from other conditions.</p>
        <p><bold>Lipomas.</bold> Other syndromes that cause multiple lipomas (e.g., multiple symmetric lipomatosis [OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/151800">151800</ext-link>]) need to be considered.</p>
      </sec>
      <sec id="merrf.Management">
        <title>Management</title>
        <sec id="merrf.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with MERRF (<italic toggle="yes">m</italic>yoclonic <italic toggle="yes">e</italic>pilepsy associated with <italic toggle="yes">r</italic>agged <italic toggle="yes">r</italic>ed <italic toggle="yes">f</italic>ibers), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Measurement of height and weight to assess growth</p>
            </list-item>
            <list-item>
              <p>Audiologic evaluation</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic evaluation</p>
            </list-item>
            <list-item>
              <p>Assessment of cognitive abilities</p>
            </list-item>
            <list-item>
              <p>Physical therapy assessment</p>
            </list-item>
            <list-item>
              <p>Neurologic evaluation, including MRI, MRS, and EEG if seizures are suspected</p>
            </list-item>
            <list-item>
              <p>Cardiac evaluation</p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation including genetic counseling</p>
            </list-item>
          </list>
        </sec>
        <sec id="merrf.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>The seizure disorder can be treated with conventional anticonvulsant therapy. No controlled studies have compared the efficacy of different anticonvulsants. Levetiracetam, clonazepam, zonisamide, and valproic acid (VPA) have been used to treat myoclonic epilepsy; however, VPA may cause secondary carnitine deficiency and should be avoided or used with L-carnitine supplementation.</p>
          <p>The myoclonus improved substantially in three of four individuals treated with levetiracetam [<xref ref-type="bibr" rid="merrf.REF.crest.2004.640">Crest et al 2004</xref>, <xref ref-type="bibr" rid="merrf.REF.mancuso.2007.1058">Mancuso et al 2007</xref>]. Clonazepam can also reduce myoclonus.</p>
          <p>Physical therapy is helpful for any impaired motor abilities.</p>
          <p>Aerobic exercise is helpful in MERRF and other mitochondrial diseases [<xref ref-type="bibr" rid="merrf.REF.taivassalo.2004.221">Taivassalo &#x00026; Haller 2004</xref>].</p>
          <p>Standard pharmacologic therapy is used to treat cardiac symptoms.</p>
        </sec>
        <sec id="merrf.Prevention_of_Primary_Manifestatio">
          <title>Prevention of Primary Manifestations</title>
          <p>The administration of coenzyme Q<sub>10</sub> (CoQ<sub>10</sub>) (50-100 mg 3x/day) and L-carnitine (1000 mg 3x/day) has been of some benefit to some individuals. In a small randomized double-blind placebo-controlled study of affected individuals with heterogeneous mitochondrial diseases, CoQ<sub>10</sub> combined with creatine and lipoic acid produced modest benefits including slowing progression of ankle weakness and lower resting plasma lactate concentration [<xref ref-type="bibr" rid="merrf.REF.rodriguez.2007.235">Rodriguez et al 2007</xref>].</p>
        </sec>
        <sec id="merrf.Surveillance">
          <title>Surveillance</title>
          <p>Affected individuals and their at-risk relatives should be followed at regular intervals (e.g. every 6-12 months initially) to monitor progression of disease and the appearance of new symptoms.</p>
          <list list-type="bullet">
            <list-item>
              <p>Annual neurologic, ophthalmologic, cardiology (electrocardiogram and echocardiogram), and endocrinologic evaluations (fasting blood sugar and TSH) are recommended.</p>
            </list-item>
            <list-item>
              <p>If normal for three years, less frequent evaluations can be considered.</p>
            </list-item>
          </list>
        </sec>
        <sec id="merrf.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Individuals with MERRF should avoid mitochondrial toxins including aminoglycoside antibiotics, linezolid, cigarettes, and alcohol. Valproic acid should be avoided in the treatment of seizures.</p>
        </sec>
        <sec id="merrf.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate relatives at risk in order to identify as early as possible those who would benefit from institution of treatment and preventive measures.</p>
          <p>If the pathogenic variant in the family is known, molecular genetic testing can be used to clarify the genetic status of at-risk relatives.</p>
          <p>See <xref ref-type="sec" rid="merrf.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="merrf.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>During pregnancy, affected or at-risk women should be monitored for diabetes mellitus and respiratory insufficiency, which may require therapeutic interventions.</p>
        </sec>
        <sec id="merrf.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>The transfer of nuclear DNA from fertilized oocytes or zygotes harboring a mtDNA pathogenic variant to a recipient enucleated recipient cell could theoretically prevent transmission of mtDNA diseases and proof of this concept has been demonstrated in pronuclear transfers from abnormally fertilized zygotes that were allowed to undergo several replications in vitro [<xref ref-type="bibr" rid="merrf.REF.craven.2010.82">Craven et al 2010</xref>].</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="merrf.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="merrf.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>MERRF is caused by pathogenic variants in mtDNA and is transmitted by maternal inheritance.</p>
        </sec>
        <sec id="merrf.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The father of a proband is not at risk of having the mtDNA pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The mother of a proband (usually) has the mtDNA pathogenic variant and may or may not have symptoms.</p>
            </list-item>
            <list-item>
              <p>Alternatively, the proband may have a <italic toggle="yes">de novo</italic> (somatic) mitochondrial pathogenic variant.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs depends on the genetic status of the mother.</p>
            </list-item>
            <list-item>
              <p>If the mother has the mtDNA pathogenic variant, all sibs of a proband will inherit the mtDNA pathogenic variant and may or may not have symptoms.</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>All offspring of females with an mtDNA pathogenic variant will inherit the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Offspring of males with a mtDNA pathogenic variant are not at risk of inheriting the pathogenic variant.</p>
            </list-item>
          </list>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the genetic status of the proband's mother.</p>
            </list-item>
            <list-item>
              <p>If the mother has an mtDNA pathogenic variant, her sibs and mother are also at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="merrf.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="merrf.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Phenotypic variability.</bold> The phenotype of an individual with a mtDNA pathogenic variant results from a combination of factors including the severity of the pathogenic variant, the percentage of mutant mitochondria (mutational load), and the organs and tissues in which they are found (tissue distribution). Different family members often inherit different percentages of mutant mtDNA and therefore can have a wide range of clinical symptoms.</p>
          <p><bold>Interpretation of testing results of asymptomatic at-risk family members</bold> is extremely difficult. Prediction of phenotype based on test results is not possible. Furthermore, absence of the mtDNA pathogenic variant in one tissue (e.g., blood) does not guarantee its absence in other tissues.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. Similarly, decisions about testing to determine the genetic status of at-risk asymptomatic family members are best made before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including general discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk; however, it is not possible to make specific predictions about the potential severity of disease in offspring.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="merrf.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the mtDNA pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing of this gene or custom prenatal testing.</p>
          <p>Interpretation of prenatal diagnostic results is complex for the following reasons:</p>
          <list list-type="bullet">
            <list-item>
              <p>The mutational load in the mother's tissues and in fetal tissues sampled (i.e., amniocytes and chorionic villi) may not correspond to that of other fetal tissues.</p>
            </list-item>
            <list-item>
              <p>Prediction of phenotype, age of onset, severity, or rate of progression is not possible.</p>
            </list-item>
          </list>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the pathogenic variant has been identified.</p>
        </sec>
      </sec>
      <sec id="merrf.Resources">
        <title>Resources</title>
      </sec>
      <sec id="merrf.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="merrf.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>The origin of mtDNA pathogenic variants is uncertain. It is also unclear how the mtDNA single nucleotide variants cause MERRF. Using rho<sup>0</sup> cell lines (permanent human cell lines emptied of their mtDNA by exposure to ethidium bromide) repopulated with mitochondria harboring the m.8344A&#x0003e;G pathogenic variant, <xref ref-type="bibr" rid="merrf.REF.chomyn.1991.2236">Chomyn et al [1991]</xref> found that high mutational loads correlated with decreased protein synthesis, decreased oxygen consumption, and cytochrome <italic toggle="yes">c</italic> oxidase deficiency. The polypeptides containing higher numbers of lysine residues were more severely affected by the pathogenic variant, suggesting that the <italic toggle="yes">MT-TK</italic> pathogenic variant directly inhibits protein synthesis. Similarly, cultured myotubes containing more than 85% mutant mtDNA showed decreased translation, especially of proteins containing large numbers of lysine residues. Cells harboring the m.8344A&#x0003e;G pathogenic variant contained decreased levels of tRNA<sup>Lys</sup> and aminoacylated tRNA<sup>Lys</sup>. The variant appears to be functionally recessive because only about 15% wild type mtDNA restores translation and cytochrome <italic toggle="yes">c</italic> oxidase activity to near-normal levels.</p>
          <p><xref ref-type="bibr" rid="merrf.REF.masucci.1995.2872">Masucci et al [1995]</xref> confirmed that protein synthesis and oxygen consumption were decreased in rho<sup>0</sup> cells repopulated with mtDNA harboring either the m.8344A&#x0003e;G or the m.8356T&#x0003e;C pathogenic variant, and identified aberrant mitochondrial protein in both cell lines, which they attributed to ribosomal frame-shifting. Studies of engineered in vitro transcribed tRNA<sup>Lys</sup> mutants showed that the pathogenic variants associated with MERRF had no effect on lysylation efficiency whereas the two pathogenic variants associated with encephalomyopathies without typical MERRF features (m.8313G&#x0003e;A and m.8328G&#x0003e;A in <italic toggle="yes">MT-TK</italic>) severely impaired lysylation [<xref ref-type="bibr" rid="merrf.REF.sissler.2004.841">Sissler et al 2004</xref>].</p>
          <p><bold>Gene structure.</bold> The mitochondrial genome is 16,569 bp in length. See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mitomap.org/MITOMAP">MITOMAP</ext-link> for genes and nucleotide variants of the mitochondrion. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="merrf" object-id="merrf.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Benign allelic variants.</bold> Benign polymorphisms are especially frequent in mtDNA and are listed at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.mitomap.org/">MITOMAP</ext-link>.</p>
          <p><bold>Pathogenic allelic variants.</bold> See <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">Table 3</xref>.</p>
          <list list-type="bullet">
            <list-item>
              <p>The mitochondrial DNA (mtDNA) gene <italic toggle="yes">MT-TK</italic> encoding tRNA lysine (tRNA<sup>Lys</sup>) is the gene most commonly associated with MERRF.</p>
            </list-item>
            <list-item>
              <p>One individual with the MERRF phenotype had the pathogenic variant <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.611G&#x0003e;A</xref> in <italic toggle="yes">MT-TF,</italic> encoding tRNA phenylalanine (tRNA<sup>Phe</sup>) [<xref ref-type="bibr" rid="merrf.REF.mancuso.2004.2119">Mancuso et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p>One child age eight years with the MERRF phenotype had the pathogenic variant m.4284G&#x0003e;A in <italic toggle="yes">MT-TI</italic>, encoding tRNA isoleucine (tRNA<sup>Ile</sup>) [<xref ref-type="bibr" rid="merrf.REF.hahn.2011.148">Hahn et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>One adult with progressive myoclonic epilepsy ragged-red fibers, hearing loss, and cognitive impairment had the pathogenic variant <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.4279A&#x0003e;G</xref> in <italic toggle="yes">MT-TI</italic> [<xref ref-type="bibr" rid="merrf.REF.zsurka.2013.483">Zsurka et al 2013</xref>].</p>
            </list-item>
            <list-item>
              <p>One individual presenting with the MERRF phenotype had the pathogenic variant m.3243A&#x0003e;G in <italic toggle="yes">MT-TL1</italic>, encoding tRNA leucine(UUR) (tRNA<sup>Leu(UUR)</sup>) [<xref ref-type="bibr" rid="merrf.REF.brackmann.2012.859">Brackmann et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>One individual presented with MERRF and pigmentary retinopathy caused by the <xref ref-type="table" rid="merrf.T.pathogenic_variants_in_mitochond">m.15967G&#x0003e;A</xref> pathogenic variant in <italic toggle="yes">MT-TP</italic> [<xref ref-type="bibr" rid="merrf.REF.blakely.2009.399">Blakely et al 2009</xref>].</p>
            </list-item>
          </list>
          <table-wrap id="merrf.T.pathogenic_variants_in_mitochond" position="anchor" orientation="portrait">
            <label>Table 3. </label>
            <caption>
              <p>Pathogenic Variants in Mitochondrial DNA Associated with MERRF</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mitochondrial DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                  <th id="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                  <th id="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequence</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">m.8344A&#x0003e;G<break/>(A8344G)<hr/></td>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" rowspan="4" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">MT-TK</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_3" rowspan="10" valign="middle" align="left" colspan="1">No protein translated</td>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_4" rowspan="10" valign="middle" align="left" colspan="1">
                    <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/251831106">NC_012920.1</ext-link>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">m.8356T&#x0003e;C<break/>(T8356C)<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">m.8363G&#x0003e;A<break/>(G8363A)<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">m.8361G&#x0003e;A<break/>(G8361A)<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">m.611G&#x0003e;A<break/>(G611A)<hr/></td>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TF</italic>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">m.3243A&#x0003e;G<break/>(A3243G)<hr/></td>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TL1</italic>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">m.4279A&#x0003e;G<break/>(A4279G)<hr/></td>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">MT-TI</italic>
                    <hr/>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">m.4284G&#x0003e;A<break/>(G4284A)<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">m.15923A&#x0003e;G<break/>(A15923G)<hr/></td>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_2" rowspan="2" valign="middle" align="left" colspan="1">
                    <italic toggle="yes">MT-TP</italic>
                  </td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.T.pathogenic_variants_in_mitochond_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">m.15967G&#x0003e;A<break/>(G15967A)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="merrf.TF.3.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> The genes encode tRNAs that are indispensable for the incorporation of these amino acids into nascent mitochondrial proteins:</p>
          <table-wrap id="merrf.Tc" position="anchor" orientation="portrait">
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_merrf.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene</th>
                  <th id="hd_h_merrf.Tc_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Amino Acid</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_merrf.Tc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TK</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_merrf.Tc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mitochondrially encoded tRNA lysine<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.Tc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TF</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_merrf.Tc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mitochondrially encoded tRNA phenylalanine<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.Tc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TL1</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_merrf.Tc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mitochondrially encoded tRNA leucine UUR<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.Tc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TI</italic>
                    <hr/>
                  </td>
                  <td headers="hd_h_merrf.Tc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mitochondrially encoded tRNA threonine<hr/></td>
                </tr>
                <tr>
                  <td headers="hd_h_merrf.Tc_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <italic toggle="yes">MT-TP</italic>
                  </td>
                  <td headers="hd_h_merrf.Tc_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Mitochondrially encoded tRNA proline</td>
                </tr>
              </tbody>
            </table>
          </table-wrap>
          <p><bold>Abnormal gene product.</bold> See <xref ref-type="sec" rid="merrf.Molecular_Genetic_Pathogenesis">Molecular Genetic Pathogenesis</xref>.</p>
        </sec>
      </sec>
      <sec id="merrf.References">
        <title>References</title>
        <sec id="merrf.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="merrf.Literature_Cited.reflist0">
            <ref id="merrf.REF.blakely.2014.533">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alston</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lecky</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chakrabarti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Falkous</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorman</surname>
                    <given-names>GS</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Distal weakness with respiratory insufficiency caused by the m.8344A &#x0003e; G "MERRF" mutation.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>24</volume>
                <fpage>533</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">24792523</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.blakely.2009.399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trip</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swalwell</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wren</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rich</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Omer</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>A new mitochondrial transfer RNAPro gene mutation associated with myoclonic epilepsy with ragged-red fibers and other neurological features.</article-title>
                <source>Arch Neurol</source>
                <volume>66</volume>
                <fpage>399</fpage>
                <lpage>402</lpage>
                <pub-id pub-id-type="pmid">19273760</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.brackmann.2012.859">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brackmann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abicht</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahting</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroder</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trollmann</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Classical MERRF phenotype associated with mitochondrial tRNA(Leu) (m.3243A&#x0003e;G) mutation.</article-title>
                <source>Eur J Pediatr</source>
                <volume>171</volume>
                <fpage>859</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">22270878</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.chomyn.1991.2236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chomyn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meola</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bresolin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarlato</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attardi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>In vitro genetic transfer of protein synthesis and respiration defects to mitochondrial DNA-less cells with myopathy-patient mitochondria.</article-title>
                <source>Mol Cell Biol</source>
                <volume>11</volume>
                <fpage>2236</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">1848674</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.craven.2010.82">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Craven</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuppen</surname>
                    <given-names>HA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greggains</surname>
                    <given-names>GD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harbottle</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murphy</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cree</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murdoch</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lightowlers</surname>
                    <given-names>RN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herbert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <article-title>Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease.</article-title>
                <source>Nature.</source>
                <year>2010</year>
                <volume>465</volume>
                <fpage>82</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20393463</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.crest.2004.640">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crest</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupont</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leguern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adam</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baulac</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>640</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">14981187</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.crimi.2003.1857">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Crimi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galbiati</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroni</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bordoni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perini</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamantea</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sciacco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biunno</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarlato</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A missense mutation in the mitochondrial ND5 gene associated with a Leigh-MELAS overlap syndrome.</article-title>
                <source>Neurology</source>
                <volume>60</volume>
                <fpage>1857</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">12796552</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.darin.2001.377">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Darin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oldfors</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moslemi</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holme</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tulinius</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA abnormalities.</article-title>
                <source>Ann Neurol</source>
                <volume>49</volume>
                <fpage>377</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">11261513</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.dimauro.2005.222">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidzon</surname>
                    <given-names>G.</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial DNA and disease.</article-title>
                <source>Ann Med.</source>
                <year>2005</year>
                <volume>37</volume>
                <fpage>222</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">16019721</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.emmanuele.2011.448">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Emmanuele</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silvers</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sotiriou</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanji</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>MERRF and Kearns-Sayre overlap syndrome due to the mitochondrial DNA m.3291T&#x0003e;C mutation.</article-title>
                <source>Muscle Nerve</source>
                <volume>44</volume>
                <fpage>448</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">21996807</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.erol.2009.275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Erol</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alehan</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneiderat</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talim</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Demyelinating disease of central and peripheral nervous systems associated with a A8344G mutation in tRNALys.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>19</volume>
                <fpage>275</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19269823</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.fujioka.2014.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fujioka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tandler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosca</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McCandless</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katirji</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rapisuwon</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoppel</surname>
                    <given-names>CL</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Multiple muscle cell alterations in a case of encephalomyopathy.</article-title>
                <source>Ultrastruct Pathol</source>
                <volume>38</volume>
                <fpage>13</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">24134831</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.hahn.2011.148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hahn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schanzer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neubauer</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gizewski</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahting</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rolinski</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>MERRF-like phenotype associated with a rare mitochondrial tRNAIle mutation (m.4284 G&#x0003e;A).</article-title>
                <source>Neuropediatrics</source>
                <volume>42</volume>
                <fpage>148</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">21766266</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.hallmann.2014.2183">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hallmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zsurka</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moskau-Hartmann</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korinthenberg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruppert</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozdemir</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elger</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiele</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nurnberg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sander</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunz</surname>
                    <given-names>WS</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>A homozygous splice-site mutation in CARS2 is associated with progressive myoclonic epilepsy.</article-title>
                <source>Neurology</source>
                <volume>83</volume>
                <fpage>2183</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">25361775</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.herreromart_n.2010.471">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Herrero-Mart&#x000ed;n</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tu&#x000f1;&#x000f3;n</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mart&#x000ed;n</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruiz-Pesini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montoya</surname>
                    <given-names>J. A</given-names>
                  </name>
                </person-group>
                <article-title>MELAS/MERRF phenotype associated with the mitochondrial DNA 5521G&#x0003e;A mutation.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <year>2010</year>
                <volume>81</volume>
                <fpage>471</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">20360171</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.hirano.1996">
              <mixed-citation publication-type="book">Hirano M, DiMauro S. Clinical features of mitochondrial myopathies and encephalomyopathies. In: Lane RJM, ed. <italic toggle="yes">Handbook of Muscle Disease</italic>. New York, NY: Marcel Dekker Inc; 1996:479-504.</mixed-citation>
            </ref>
            <ref id="merrf.REF.horvath.2007.56">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Horvath</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kley</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lochmuller</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vorgerd</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Parkinson syndrome, neuropathy, and myopathy caused by the mutation A8344G (MERRF) in tRNALys.</article-title>
                <source>Neurology</source>
                <volume>68</volume>
                <fpage>56</fpage>
                <lpage>58</lpage>
                <pub-id pub-id-type="pmid">17200493</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.hunt.1921.490">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hunt</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>1921</year>
                <article-title>Dyssynergia cerebellaris myoclonia-primary atrophy of the dentate system: a contribution to the pathology and symptomatology of the cerebellum.</article-title>
                <source>Brain</source>
                <volume>44</volume>
                <fpage>490</fpage>
                <lpage>538</lpage>
              </element-citation>
            </ref>
            <ref id="merrf.REF.ito.2008.392">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shirai</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asahina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Clinical and brain MR imaging features focusing on the brain stem and cerebellum in patients with myoclonic epilepsy with ragged-red fibers due to mitochondrial A8344G mutation.</article-title>
                <source>AJNR Am J Neuroradiol</source>
                <volume>29</volume>
                <fpage>392</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17989367</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.mancuso.2004.2119">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mancuso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filosto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mootha</surname>
                    <given-names>VK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rocchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pistolesi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Murri</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siciliano</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A novel mitochondrial tRNAPhe mutation causes MERRF syndrome.</article-title>
                <source>Neurology</source>
                <volume>62</volume>
                <fpage>2119</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">15184630</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.mancuso.2013.2049">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mancuso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orsucci</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Angelini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertini</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Comi</surname>
                    <given-names>GP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moggio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mongini</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Servidei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toscano</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uziel</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caldarazzo Ienco</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filosto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamperti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moroni</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Musumeci</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pegoraro</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronchi</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sauchelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scarpelli</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sciacco</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinazzi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vercelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siciliano</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Phenotypic heterogeneity of the 8344A&#x0003e;G mtDNA "MERRF" mutation.</article-title>
                <source>Neurology</source>
                <volume>80</volume>
                <fpage>2049</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">23635963</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.mancuso.2007.1058">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mancuso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrozzi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filosto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nesti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rocchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choub</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pistolesi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massentani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fontanini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siciliano</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>MERRF syndrome without ragged-red fibers: the need for molecular diagnosis.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>354</volume>
                <fpage>1058</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">17275787</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.mart_njim_nez.2012.288">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;n-Jim&#x000e9;nez</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin-Hernandez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabello</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Silva</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arenas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Clinical and cellular consequences of the mutation m.12300G&#x0003e;A in the mitochondrial tRNA(Leu(CUN)) gene.</article-title>
                <source>Mitochondrion</source>
                <volume>12</volume>
                <fpage>288</fpage>
                <lpage>93</lpage>
                <pub-id pub-id-type="pmid">22094595</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.masucci.1995.2872">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Masucci</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koga</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schon</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>King</surname>
                    <given-names>MP</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>In vitro analysis of mutations causing myoclonus epilepsy with ragged-red fibers in the mitochondrial tRNA(Lys)gene: two genotypes produce similar phenotypes.</article-title>
                <source>Mol Cell Biol</source>
                <volume>15</volume>
                <fpage>2872</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">7739567</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.melone.2004.269">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Melone</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tessa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petrini</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lus</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sampaolo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>di Fede</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santorelli</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotrufo</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERRF phenotype.</article-title>
                <source>Arch Neurol</source>
                <volume>61</volume>
                <fpage>269</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">14967777</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.molnar.2009.264">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Molnar</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perenyi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Siska</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nemeth</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nagy</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>The typical MERRF (A8344G) mutation of the mitochondrial DNA associated with depressive mood disorders.</article-title>
                <source>J Neurol</source>
                <volume>256</volume>
                <fpage>264</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">19266142</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.naini.2005.473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Naini</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernstein</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancuso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Novel mitochondrial DNA ND5 mutation in a patient with clinical features of MELAS and MERRF.</article-title>
                <source>Arch Neurol</source>
                <volume>62</volume>
                <fpage>473</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">15767514</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.nakamura.2010.659">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yabe</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sudo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hosoki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yaguchi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitoh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sasaki</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes.</article-title>
                <source>J Med Genet</source>
                <volume>47</volume>
                <fpage>659</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">20610441</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.nishigaki.2003.334">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishigaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tadesse</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonilla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shungu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hersh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keats</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berlin</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldberg</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vockley</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A novel mitochondrial tRNA(Leu(UUR)) mutation in a patient with features of MERRF and Kearns-Sayre syndrome.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>13</volume>
                <fpage>334</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">12868503</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.orcesi.2006.79">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Orcesi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorni</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Termine</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uggetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veggiotti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrara</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zeviani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berardinelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lanzi</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Bilateral putaminal necrosis associated with the mitochondrial DNA A8344G myoclonus epilepsy with ragged red fibers (MERRF) mutation: an infantile case.</article-title>
                <source>J Child Neurol</source>
                <volume>21</volume>
                <fpage>79</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">16551460</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.peng.2003.716">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crumley</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ringman</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Spasmodic dysphonia in a patient with the A to G transition at nucleotide 8344 in mitochondrial DNA.</article-title>
                <source>Mov Disord</source>
                <volume>18</volume>
                <fpage>716</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12784281</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.remes.2005.976">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Remes</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majamaa-Voltti</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karppa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moilanen</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uimonen</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helander</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rusanen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salmela</surname>
                    <given-names>PI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sorri</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hassinen</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majamaa</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population.</article-title>
                <source>Neurology</source>
                <volume>64</volume>
                <fpage>976</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">15781811</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.rodriguez.2007.235">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahoney</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parise</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beal</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tarnopolsky</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders.</article-title>
                <source>Muscle Nerve</source>
                <volume>35</volume>
                <fpage>235</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">17080429</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.rossmanith.2003.820">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rossmanith</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raffelsberger</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roka</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornek</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feucht</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bittner</surname>
                    <given-names>RE</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The expanding mutational spectrum of MERRF substitution G8361A in the mitochondrial tRNALys gene.</article-title>
                <source>Ann Neurol</source>
                <volume>54</volume>
                <fpage>820</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">14681892</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.schaefer.2008.35">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whittaker</surname>
                    <given-names>RG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Prevalence of mitochondrial DNA disease in adults.</article-title>
                <source>Ann Neurol</source>
                <volume>63</volume>
                <fpage>35</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17886296</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.shtilbans.2000.759">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shtilbans</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goodman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sue</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruno</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lava</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waheed</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>G8363A mutation in the mitochondrial DNA transfer ribonucleic acidLys gene: another cause of Leigh syndrome.</article-title>
                <source>J Child Neurol</source>
                <volume>15</volume>
                <fpage>759</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">11108511</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.sissler.2004.841">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sissler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Helm</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frugier</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giege</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florentz</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Aminoacylation properties of pathology-related human mitochondrial tRNA(Lys) variants.</article-title>
                <source>RNA</source>
                <volume>10</volume>
                <fpage>841</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">15100439</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.taivassalo.2004.221">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Taivassalo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haller</surname>
                    <given-names>RG</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Implications of exercise training in mtDNA defects--use it or lose it?</article-title>
                <source>Biochim Biophys Acta</source>
                <volume>1659</volume>
                <fpage>221</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">15576055</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.vallance.2004.538">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vallance</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jeven</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>A case of sporadic infantile histiocytoid cardiomyopathy caused by the A8344G (MERRF) mitochondrial DNA mutation.</article-title>
                <source>Pediatr Cardiol</source>
                <volume>25</volume>
                <fpage>538</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">15164143</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.van_de_glind.2007.243">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van de Glind</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodenburg</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hol</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smeitink</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morava</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Resting muscle pain as the first clinical symptom in children carrying the MTTK A8344G mutation.</article-title>
                <source>Eur J Paediatr Neurol</source>
                <volume>11</volume>
                <fpage>243</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17293137</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.van_goethem.2003.1811">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Van Goethem</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mercelis</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>L&#x000f6;fgren</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seneca</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceuterick</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Patient homozygous for a recessive POLG mutation presents with features of MERRF.</article-title>
                <source>Neurology.</source>
                <volume>61</volume>
                <fpage>1811</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">14694057</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.vastagh.2011.399">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vastagh</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Remenyi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semjen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lukacs</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valikovics</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Molnar</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>A8344G mutation of the mitochondrial DNA with typical mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes syndrome.</article-title>
                <source>Ideggyogy Sz</source>
                <volume>64</volume>
                <fpage>399</fpage>
                <lpage>403</lpage>
                <pub-id pub-id-type="pmid">22611618</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.wahbi.2010.674">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wahbi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larue</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jardel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meune</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stojkovic</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ziegler</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lombes</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eymard</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duboc</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laforet</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Cardiac involvement is frequent in patients with the m.8344A&#x0003e;G mutation of mitochondrial DNA.</article-title>
                <source>Neurology</source>
                <volume>74</volume>
                <fpage>674</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">20177121</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.wiedemann.2008.859">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wiedemann</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartels</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirches</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mawrin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallesch</surname>
                    <given-names>CW</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Unusual presentations of patients with the mitochondrial MERRF mutation A8344G.</article-title>
                <source>Clin Neurol Neurosurg</source>
                <volume>110</volume>
                <fpage>859</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">18657354</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.yoon.1993.433">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yoon</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ernst</surname>
                    <given-names>SG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasmussen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dooling</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aprille</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Mitochondrial disorder associated with newborn cardiopulmonary arrest.</article-title>
                <source>Pediatr Res</source>
                <volume>33</volume>
                <fpage>433</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">8511015</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.yorns.2012.398">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yorns</surname>
                    <given-names>WR</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Valencia</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jayaraman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheth</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legido</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldenthal</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Buccal swab analysis of mitochondrial enzyme deficiency and DNA defects in a child with suspected myoclonic epilepsy and ragged red fibers (MERRF).</article-title>
                <source>J Child Neurol</source>
                <volume>27</volume>
                <fpage>398</fpage>
                <lpage>401</lpage>
                <pub-id pub-id-type="pmid">22114216</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.zsurka.2013.483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zsurka</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Becker</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gdynia</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunz</surname>
                    <given-names>WS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>YG</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Mutation in the mitochondrial tRNA(Ile) gene causes progressive myoclonus epilepsy.</article-title>
                <source>Seizure</source>
                <volume>22</volume>
                <fpage>483</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23601850</pub-id>
              </element-citation>
            </ref>
            <ref id="merrf.REF.zupanc.2004.156">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zupanc</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Legros</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Progressive myoclonic epilepsy.</article-title>
                <source>Cerebellum</source>
                <volume>3</volume>
                <fpage>156</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">15543806</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="merrf.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="merrf.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>29 January 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>18 August 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>27 September 2005 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>3 June 2003 (ca) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>8 May 2003 (sdm) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
